Literature DB >> 26667098

Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus.

Kim A Connelly1, Andrew T Yan2, Lawrence A Leiter2, Deepak L Bhatt2, Subodh Verma1.   

Abstract

Entities:  

Keywords:  diabetes mellitus; drug therapy; hypoglycemia; patient outcome assessment; type 2

Mesh：

Substances：

Year:  2015        PMID： 26667098     DOI： 10.1161/CIRCULATIONAHA.115.015946

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

Review 1.  Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting.

Authors:  Stacey A Seggelke; Mark C Lindsay; Ingrid Hazlett; Rebecca Sanagorski; Robert H Eckel; Cecilia C Low Wang
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

2.  Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society.

Authors:  Eiichi Araki; Atsushi Tanaka; Nobuya Inagaki; Hiroshi Ito; Kohjiro Ueki; Toyoaki Murohara; Kenjiro Imai; Masataka Sata; Takehiro Sugiyama; Hideki Ishii; Shunsuke Yamane; Takashi Kadowaki; Issei Komuro; Koichi Node
Journal:  Diabetol Int       Date:  2020-11-30

3.  Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis.

Authors:  Subodh Verma; Ronald M Goldenberg; Deepak L Bhatt; Michael E Farkouh; Adrian Quan; Hwee Teoh; Kim A Connelly; Lawrence A Leiter; Jan O Friedrich
Journal:  CMAJ Open       Date:  2017-02-24

Review 4.  [Sudden cardiac death in diabetes mellitus].

Authors:  C W Israel; Y H Lee-Barkey
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

Review 5.  Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.

Authors:  Volker Vallon; Subodh Verma
Journal:  Annu Rev Physiol       Date:  2020-11-16       Impact factor: 19.318

6.  Network Pharmacology-Based Identification of the Mechanisms of Shen-Qi Compound Formula in Treating Diabetes Mellitus.

Authors:  Zhipeng Hu; Maoyi Yang; Liangjun Yang; Chunguang Xie; Hong Gao; Xiaoxu Fu; Hongyan Xie; Ya Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-04       Impact factor: 2.629

7.  Efficacy and short-term side effects of sitagliptin, vildagliptin and saxagliptin in Chinese diabetes: a randomized clinical trial.

Authors:  Xiao-Jun Zhou; Lin Ding; Jia-Xin Liu; Le-Qun Su; Jian-Jun Dong; Lin Liao
Journal:  Endocr Connect       Date:  2019-04       Impact factor: 3.335

8.  Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study.

Authors:  Jae-Seung Yun; Yong-Moon Park; Kyungdo Han; Seon-Ah Cha; Yu-Bae Ahn; Seung-Hyun Ko
Journal:  Cardiovasc Diabetol       Date:  2019-08-14       Impact factor: 9.951

9.  Novel Imaging of Hypoglycemia-induced Myocardial Abnormality by Cardiac Magnetic Resonance T1-mapping.

Authors:  Taisuke Nakade; Hitoshi Sumida; Kazuhiro Katahira; Kenro Nishida
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

10.  Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia.

Authors:  Desye Gebrie; Tsegahun Manyazewal; Dawit A Ejigu; Eyasu Makonnen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-24       Impact factor: 3.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.